News Focus
News Focus
icon url

Rotten Johnny

01/07/14 9:31 PM

#91426 RE: brickbybrick #91425

nice drill down - I saw that as well

http://biz.yahoo.com/e/130613/ambs8-k.html

Item 8.01 Other Events

On May 22, 2013, the Company entered into a letter of intent to in-license a Phase 2 drug candidate in L-Dopa-Induced Dyskinesia Parkinson’s Disease from an undisclosed third party. Once licensed the Company intends to initiate a Phase 2b clinical trial within 12 months.